This page lists all pharmaceutical reports related to the field of Cancer Immunotherapy. The reports include market research reports and pipeline analyses.
Displaying 1 - 50 of 130 results
- The Emerging Cancer Vaccine Market
- Cancer Stem Cells: Emerging Therapeutic, Diagnostics and Market Opportunities
- Drug Delivery in Cancer - technologies, markets and companies
- Cell Therapy - Technologies, Markets and Companies
- Cancer Diagnostic Testing World Markets
- Cancer Therapeutics Markets
- Therapeutic Monoclonal Antibodies, 2006-2011
- World market for cancer vaccines 2007-2012
- Pipeline Insight: Hematological Malignancies - Pursuit for the next blockbuster intensifies
- Early Toxicology: Markets and Approaches
- Melanoma - Lucrative commercial opportunities persist
- Therapeutic Cancer Vaccines - A turbulent path from bench to bedside
- Gynecological Cancers - Niche opportunities in advanced disease
- Non-Small Cell Lung Cancer
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Colorectal Cancer - Shaping the future dynamics of colorectal cancer management
- Molecular Targeted Cancer Therapies - More drugs on the market, more targets in the pipeline
- Supportive Care in Cancer Treatment - Some first-generation products proving difficult to dislodge
- Pipeline Insight: Breast Cancer - A diverse and increasingly crowded pipeline
- Pipeline Insight: Cancer Overview Emerging Therapeutic and Commercial Opportunities
- From Blockbuster to Nichebuster
- Commercial Insight Top 20 Cancer Therapeutics
- Ovarian Cancer: Growing importance as secondary indication for targeted therapies
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Cancer Therapeutics 2006
- Biogenerics
- Cancer Vaccines Measuring Market Potential
- Acute Leukemias - Persistent unmet needs confer significant commercial opportunity
- Gastric Cancer - Targeted Therapies Home In On a Neglected Tumor Type
- Preclinical Cancer Therapeutics 2007
- Chemotherapy Market Insights, 2006-2016
- Renal Cell Carcinoma - Novel Targeted Treatments to Fill the Void
- Therapeutic Vaccines
- Biogenerics 2005: A New Level of Complexity
- Myelodysplastic Syndrome - An underserved population offers commercial opportunity
- Stakeholder Insight: Prostate Cancer
- Chronic Leukemias - Curative Intent Raises the Bar
- Innovative Targeted Oncology Therapies
- Optimizing Targeted Treatment in Cancer: Negotiating the Challenges to Success
- Pipeline Insight: Hematological malignancies - Targeted treatments & immunotherapy
- Monoclonal Antibody Therapies: Evolving into a $30 billion market
- Breast Cancer - Changing Treatment Paradigms for Local and Locally Advanced Breast Cancer
- Pipeline Insight: Cancer Vaccines and Cell Therapies
- Cancer Market Top 20 Drugs - Supportive Care Grows the Cancer Market
- Cancer Biomarkers: Enhancing diagnostic, therapeutic and developmental strategies
- Non-Small Cell Lung Cancer - Angiogenesis and signal transduction inhibitors to expand market
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Hepatocellular Carcinoma - Opportune indication for novel therapies
- Supportive Care in Oncology-Significant growth opportunities in new supportive care indications